Surveillance of Ocular Surface Flora (SURFACE)

Completed

Conditions studied: Cataract

In brief

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance of ocular isolates to commonly used topical antibiotics.

Key facts

Study ID

NCT00621933

Run by

Allergan

People needed

399

Starts

2007-12-01

Expected to finish

2008-11-01

Last updated by the study team

2019-04-26

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled to undergo cataract surgery
• Able to provide written informed consent

You may not qualify if…

• NSAID in the eye to be swabbed within the past 30 days
• Topical anesthetic, topical antibiotic or antiseptic, or dilating drops in the eye to the swabbed within the past 7 days
• Over-the-counter artificial tear drops or astringent /redness reliever drops (e.g., Visine®, Clear eyes® in the eye to be swabbed on the day of trial
• History of conjunctivitis or any ocular infection within the past 3 months

Where it is running

• Study site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.